Foretinib Withdrawn Phase 2 Trials for Cancer Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02034097A Study to Evaluate Foretinib in Subjects With Non-Small-Cell Lung Cancer